NYSE · CIK 0001718500
AXIL Reviv3 Procare Co
Insider trading from SEC Form 4. Last filing Mar 4, 2026.
In brief
Reviv3 Procare Co (AXIL) has 14 SEC Form 4 filings on file from 6 insiders, the latest filed on Mar 4, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
2 open-market trades have been scored at AXIL. The newest: Nancy Hundt (director) sold $252k of stock on Oct 18, 2023, filed Oct 19, 2023, scored 48 (moderate).
Last 90 days
Signals
Open-market buys and sells at Reviv3 Procare Co, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | Nancy Hundt director sell | $252k 2,100,000 shares | -98% | - | |
| 41Moderate | Jeff Toghraie Chairman, CEO buy | $252k 2,100,000 shares | +9% | - |
Transactions
Every row filed, 16 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 15, 2026 | Manu Ohri director | AGrant or award Common Stock | +5,000 | $0.00 | $0 | 15,001 | Mar 4, 2026 |
| Jan 15, 2026 | Nancy Hundt director | AGrant or award Common Stock | +5,000 | $0.00 | $0 | 17,273 | Jan 20, 2026 |
| Jan 15, 2026 | Thomas Penna director | AGrant or award Common Stock | +5,000 | $0.00 | $0 | 23,000 | Jan 20, 2026 |
| Nov 3, 2025 | Jeffrey B. Brown CFO, COO | CConversion Common Stockindirect: By BZ Capital Strategies | +45,000 | - | - | 145,000 | Nov 3, 2025 |
| Nov 3, 2025 | Jeffrey B. Brown CFO, COO | CConversion Series A Preferred Stockderivativeindirect: By BZ Capital Strategies | -900,000 | - | - | 300,000 | Nov 3, 2025 |
| Oct 28, 2025 | Jeffrey B. Brown CFO, COO | POpen-market purchase Series A Preferred Stockderivativeindirect: By BZ Capital Strategies | +1,200,000 | - | - | 1,200,000 | Oct 30, 2025 |
| Jan 13, 2025 | Nancy Hundt director | AGrant or award Common Stock | +5,000 | $0.00 | $0 | 12,273 | Jan 13, 2025 |
| Jan 13, 2025 | Manu Ohri director | AGrant or award Common Stock | +5,000 | $0.00 | $0 | 10,001 | Jan 13, 2025 |
| Jan 13, 2025 | Peter Philip Dunne director | AGrant or award Common Stock | +5,000 | $0.00 | $0 | 31,250 | Jan 13, 2025 |
| Jan 10, 2025 | Jeffrey B. Brown CFO, COO | CConversion Common Stockindirect: By BZ Capital Strategies | +100,000 | - | - | 100,000 | Jan 13, 2025 |
| Jan 10, 2025 | Jeffrey B. Brown CFO, COO | CConversion Series A Preferred Stockderivativeindirect: By BZ Capital Strategies | -2,000,000 | - | - | 0 | Jan 13, 2025 |
| Nov 8, 2024 | Jeffrey B. Brown CFO, COO | POpen-market purchase Series A Preferred Stockderivativeindirect: By BZ Capital Strategies | +2,000,000 | - | - | 2,000,000 | Nov 12, 2024 |
| Oct 14, 2024 | Jeffrey B. Brown CFO, COO | AGrant or award Stock Option (right to buy)derivative | +250,000 | $0.00 | $0 | 250,000 | Oct 15, 2024 |
| Oct 14, 2024 | Jeff Toghraie Chairman, CEO | AGrant or award Stock Option (right to buy)derivative | +350,000 | $0.00 | $0 | 350,000 | Oct 15, 2024 |
| Oct 18, 2023 | Nancy Hundt director | SOpen-market sale Common Stock | -2,100,000 | $0.12 | $252k | 45,455 | Oct 19, 2023 |
| Oct 18, 2023 | Jeff Toghraie Chairman, CEO | POpen-market purchase Common Stockindirect: By Intrepid Global Advisors | +2,100,000 | $0.12 | $252k | 24,934,000 | Oct 19, 2023 |
Insiders
Everyone who has filed a Form 4 here.
- Jeffrey B. BrownCFO, COO
- Peter Philip Dunnedirector
- Nancy Hundtdirector
- Manu Ohridirector
- Thomas Pennadirector
- Jeff ToghraieChairman, CEO
Questions about AXIL
Answered from the filings on this page, as of the latest one.
Are insiders buying AXIL?
No. In the last 90 days no insider at Reviv3 Procare Co bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade AXIL on the open market?
Nancy Hundt (director) sold $252k of AXIL on Oct 18, 2023 and filed the Form 4 on Oct 19, 2023. InsiderTell scored 48 (moderate).
How many insiders file Form 4 at Reviv3 Procare Co?
6 people have filed a Form 4 at Reviv3 Procare Co, among them Jeffrey B. Brown (CFO, COO), Peter Philip Dunne (director), Nancy Hundt (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.